Interleukin-7 is decreased and maybe plays a pro-inflammatory function in primary immune thrombocytopenia

References

• Semple JW. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev 2002;16:9–12
   PubMed Web of Science ®Google Scholar
• Panitsas FP, Theodoropoulou M, Kouraklis A, Karakantza M, Theodorou GL, Zoumbos NC, Maniatis A, Mouzaki A. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood 2004;103:2645–2647
   PubMed Web of Science ®Google Scholar
• Ogawara H, Handa H, Morita K, Hayakawa M, Kojima J, Amagai H, Tsumita Y, Kaneko Y, Tsukamoto N, Nojima Y, et al. High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol 2003;71:283–288
   PubMed Web of Science ®Google Scholar
• Semple JW, Milev Y, Cosgrave D, Mody M, Hornstein A, Blanchette V, Freedman J. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: Relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood 1996;87:4245–4254
   PubMed Web of Science ®Google Scholar
• Olsson B, Andersson PO, Jernås M, Jacobsson S, Carlsson B, Carlsson LM, Wadenvik H. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 2003;9:1123–1124
   PubMed Web of Science ®Google Scholar
• Liu B, Zhao H, Poon MC, Han Z, Gu D, Xu M, Jia H, Yang R, Han ZC. Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol 2007;78:139–143
   PubMed Web of Science ®Google Scholar
• Ling Y, Cao X, Yu Z, Ruan C. Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur J Haematol 2007;79:310–316
   PubMed Web of Science ®Google Scholar
• Catani L, Fagioli ME, Tazzari PL, Ricci F, Curti A, Rovito M, Preda P, Chirumbolo G, Amabile M, Lemoli RM, et al. Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes. Exp Hematol 2006;34:879–887
   PubMed Web of Science ®Google Scholar
• Hauch TW, Rosse WF. Platelet-bound complement (C3) in immune thrombocytopenia. Blood 1977;50:1129–1136
   PubMedGoogle Scholar
• Semple JW, Bruce S, Freedman J. Suppressed natural killer cell activity in patients with chronic autoimmune thrombocytopenic purpura. Am J Hematol 1991;37:258–262
   PubMed Web of Science ®Google Scholar
• Olsson B, Andersson PO, Jacobsson S, Carlsson L, Wadenvik H. Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura. Thromb Haemost 2005;93:139–144
   PubMed Web of Science ®Google Scholar
• Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest 1998;102:1393–1402
   PubMed Web of Science ®Google Scholar
• Bradley LM, Haynes L, Swain SL. IL-7: Maintaining T-cell memory and achieving homeostasis. Trends Immunol 2005;26:172–176
   PubMed Web of Science ®Google Scholar
• Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, Solomon M, Selby W, Alexander SI, Nanan R, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006;203:1693–1700
   PubMed Web of Science ®Google Scholar
• Kim K, Lee CK, Sayers TJ, Muegge K, Durum SK. The trophic action of IL-7 on pro-T cells: Inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J Immunol 1998;160:5735–5741
   PubMedGoogle Scholar
• Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, Gress RE. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 2001;97:1491–1497
   PubMed Web of Science ®Google Scholar
• Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003;4:1191–1198
   PubMed Web of Science ®Google Scholar
• Unsinger J, McGlynn M, Kasten KR, Hoekzema AS, Watanabe E, Muenzer JT, McDonough JS, Tschoep J, Ferguson TA, McDunn JE, et al. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol 2010;184:3768–3779
   PubMed Web of Science ®Google Scholar
• Fry TJ, Mackall CL. Interleukin-7: From bench to clinic. Blood 2002;99:3892–3904
   PubMed Web of Science ®Google Scholar
• Napolitano LA, Grant RM, Deeks SG, Schmidt D, De Rosa SC, Herzenberg LA, Herndier BG, Andersson J, McCune JM. Increased producton of IL-7 accompanies HIV-1-mediated T-cell depletion: Implications for T-cell homeostasis. Nat Med 2001;7:73–79
   PubMed Web of Science ®Google Scholar
• Hartgring SA, Willis CR, Bijlsma JW, Lafeber FP, van Roon JA. Interleukin-7-aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activation. Arthritis Res Ther 2012;14:R137
   Google Scholar
• Lee LF, Axtell R, Tu GH, Logronio K, Dilley J, Yu J, Rickert M, Han B, Evering W, Walker MG, et al. IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-beta in multiple sclerosis. Sci Transl Med 2011;3:93ra68
   PubMed Web of Science ®Google Scholar
• Lee LF, Logronio K, Tu GH, Zhai W, Ni I, Mei L, Dilley J, Yu J, Rajpal A, Brown C,et al. Anti-IL-7 receptor-alpha reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function. Proc Natl Acad Sci USA 2012;109:12674–12679
   PubMedGoogle Scholar
• Makino T, Fukushima S, Wakasugi S, Ihn H. Decreased serum IL-7 levels in patients with systemic sclerosis. Clin Exp Rheumatol 2009;27:68–69
   PubMedGoogle Scholar
• Andreu-Ballester JC, Pérez-Griera J, Garcia-Ballesteros C, Amigo V, Catalán-Serra I, Monforte-Albalat A, Bixquert-Jiménez M, Ballester F. Deficit of interleukin-7 in serum of patients with Crohn's disease. Inflamm Bowel Dis 2013;19:E30–E31
   PubMedGoogle Scholar
• Traggiai E, Biagioli T, Rosati E, Ballerini C, Mazzanti B, Ben Nun A, Massacesi L, Vergelli M. IL-7-enhanced T-cell response to myelin proteins in multiple sclerosis. J Neuroimmunol 2001;121:111–119
   PubMed Web of Science ®Google Scholar
• Pickens SR, Chamberlain ND, Volin MV, Pope RM, Talarico NE, Mandelin AM II, Shahrara S. Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2011;63:2884–2893
   PubMedGoogle Scholar
• Kreft KL, Verbraak E, Wierenga-Wolf AF, van Meurs M, Oostra BA, Laman JD, Hintzen RQ. Decreased systemic IL-7 and soluble IL-7Ralpha in multiple sclerosis patients. Genes Immun 2012;13:587–592
   PubMedGoogle Scholar
• Goëb V, Aegerter P, Parmar R, Fardellone P, Vittecoq O, Conaghan PG, Emery P, Le Loët X, Ponchel F. Progression to rheumatoid arthritis in early inflammatory arthritis is associated with low IL-7 serum levels. Ann Rheum Dis 2013;72:1032–1036
   PubMedGoogle Scholar
• Ponchel F, Verburg RJ, Bingham SJ, Brown AK, Moore J, Protheroe A, Short K, Lawson CA, Morgan AW, Quinn M, et al. Interleukin-7 deficiency in rheumatoid arthritis: Consequences for therapy-induced lymphopenia. Arthritis Res Ther 2005;7:R80–R92
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009;113:2386–2393
   PubMed Web of Science ®Google Scholar
• Dennig D, Lacerda J, Yan Y, Gasparetto C, O'Reilly RJ. ICAM-1 (CD54) expression on B lymphocytes is associated with their costimulatory function and can be increased by coactivation with IL-1 and IL-7. Cell Immunol 1994;156:414–423
   PubMedGoogle Scholar
• Dennig D, O'Reilly RJ. IL-7 induces surface expression of B7/BB1 on pre-B cells and an associated increase in their costimulatory effects on T cell proliferation. Cell Immunol 1994;153:227–238
   PubMedGoogle Scholar
• Lynch DH, Miller RE. Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo. J Exp Med 1994;179:31–42
   PubMed Web of Science ®Google Scholar
• Simonetta F, Gestermann N, Martinet KZ, Boniotto M, Tissières P, Seddon B, Bourgeois C. Interleukin-7 influences FOXP3+CD4+ regulatory T cells peripheral homeostasis. PLoS One 2012;7:e36596
   Google Scholar
• Stasi R, Evangelista ML, Stipa E, Buccisano F, Venditti A, Amadori S. Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management. Thromb Haemost 2008;99:4–13
   PubMed Web of Science ®Google Scholar
• Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R, Han ZC. Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica 2005;90:914–923
   PubMed Web of Science ®Google Scholar
• Borger P, Kauffman HF, Postma DS, Vellenga E. IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms. J Immunol 1996;156:1333–1338
   PubMed Web of Science ®Google Scholar
• Fry TJ, Connick E, Falloon J, Lederman MM, Liewehr DJ, Spritzler J, Steinberg SM, Wood LV, Yarchoan R, Zuckerman J, et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 2001;97:2983–2990
   PubMed Web of Science ®Google Scholar
• Bolotin E, Annett G, Parkman R, Weinberg K. Serum levels of IL-7 in bone marrow transplant recipients: Relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant 1999;23:783–788
   PubMed Web of Science ®Google Scholar
• Ma L, Zhou Z, Zhang D, Wang H, Li H, Xue F, Yang R. Bmi-1 regulates autoreactive CD4+ T cell survival in immune thrombocytopenia patients. J Clin Immunol 2012;32:505–513
   PubMed Web of Science ®Google Scholar
• Vranjkovic A, Crawley AM, Gee K, Kumar A, Angel JB. IL-7 decreases IL-7 receptor alpha (CD127) expression and induces the shedding of CD127 by human CD8+ T cells. Int Immunol 2007;19:1329–1339
   PubMedGoogle Scholar
• Crawley AM, Faucher S, Angel JB. Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infection. J Immunol 2010;184:4679–4687
   Google Scholar